1. Home
  2. EFOI vs PCSA Comparison

EFOI vs PCSA Comparison

Compare EFOI & PCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Focus Inc.

EFOI

Energy Focus Inc.

HOLD

Current Price

$3.81

Market Cap

10.2M

ML Signal

HOLD

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$2.87

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFOI
PCSA
Founded
1985
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2M
8.2M
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
EFOI
PCSA
Price
$3.81
$2.87
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
7.2M
50.1K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
43.75
N/A
EPS
N/A
N/A
Revenue
$3,560,000.00
$5,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$0.11
52 Week High
$9.84
$8.88

Technical Indicators

Market Signals
Indicator
EFOI
PCSA
Relative Strength Index (RSI) 54.22 52.90
Support Level $1.95 $2.76
Resistance Level $9.84 $3.26
Average True Range (ATR) 0.63 0.25
MACD -0.10 -0.02
Stochastic Oscillator 14.03 38.95

Price Performance

Historical Comparison
EFOI
PCSA

About EFOI Energy Focus Inc.

Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

Share on Social Networks: